Corrigendum: Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations
Guneet K. Jasuja, Hill L. Wolfe, Joel I. Reisman, Varsha G. Vimalananda, Sowmya R. Rao, John R. Blosnich, Nicholas A. Livingston, Jillian C. Shipherd
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSex and Gender in Healthcare
In the published article, there was an error. A sentence in the results sub-section of the abstract did not match with a sentence in the results section 3.3 “Guideline concordance on GAHT initiation” on page 5 of the published article.
A correction has been made to the Results section in the Abstract. This sentence previously stated: “Among veterans who started feminizing GAHT with estrogen, 97.0% were guideline concordant due to no documentation of venous thromboembolism, breast cancer, stroke, or myocardial infarction.”
The corrected sentence appears below.
“Among veterans who started feminizing GAHT with estrogen, 98.6% were guideline concordant due to no documentation of venous thromboembolism, or breast cancer.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.